Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:03 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 134 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Stroke Risk Clear all

Conditions: Diabetes, Diet, Epidemiology, Stroke, Myocardial Infarction
Interventions: Not listed
Lead sponsor: University of Miami; Other
Eligibility: 40 Years and older
Enrollment: 3,497 participants
Timeline: 1993 – 2022
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Atrial Fibrillation, Stroke
Interventions: Alert-based computerized decision support; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 2,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Edgewood, Kentucky • Boston, Massachusetts

Conditions: Ventricular Tachycardia, Premature Ventricular Contraction, Stroke
Interventions: DOAC, Aspirin; Drug
Lead sponsor: Kansas City Heart Rhythm Institute; Other
Eligibility: 18 Years to 80 Years
Enrollment: 246 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 4
States / cities: Kansas City, Kansas • Overland Park, Kansas • The Bronx, New York + 1 more

Conditions: Stroke
Interventions: Not listed
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 7
States / cities: Chicago, Illinois • Louisville, Kentucky • Baltimore, Maryland + 4 more

Conditions: Coronary Heart Disease (CHD)
Interventions: Evolocumab, Placebo; Drug
Lead sponsor: Amgen; Industry
Eligibility: 50 Years to 79 Years
Enrollment: 12,301 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 145
States / cities: Athens, Alabama • Birmingham, Alabama • Huntsville, Alabama + 127 more

Conditions: Coronary Heart Disease, Stroke, Hyperlipidemia, Hypertension
Interventions: Enhance health lifestyle changes and medication compliance; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 35 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2003
U.S. locations: 1
States / cities: Stanford, California

Conditions: Oneida Nation Members
Interventions: Health Wellness Coaching, Carotid ultrasound, School-age nutritional education program, Cognitive Testing, Blood work; Behavioral · Diagnostic Test
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 7 Years to 85 Years
Enrollment: 95 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Madison, Wisconsin • Oneida, Wisconsin

Conditions: Cardiovascular Disease, Peripheral Artery Disease, Ischemic Stroke, Diabetes
Interventions: Web-Based Intervention; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Coronary Heart Disease, Stroke, Breast Cancer, Ovarian Cancer, Cancer, Hip Fracture, Death
Interventions: Not listed
Lead sponsor: Parker, William H., M.D.; Other
Eligibility: 30 Years to 55 Years · Female only
Enrollment: 32,175 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1980 – 2004
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Atrial Fibrillation, Stroke
Interventions: Computer Electronic Alert; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years and older
Enrollment: 458 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Stroke, Atherosclerosis
Interventions: High Risk - intensive coaching, High Risk - standard care, Low Risk - control; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 55 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Madison, Wisconsin • Oneida, Wisconsin

Conditions: Fibrillation, Atrial, Atrial Fibrillation
Interventions: SB424323; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 640 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 9
States / cities: Mobile, Alabama • Troy, Michigan • Akron, Ohio + 6 more

Conditions: Stroke, Hypertension
Interventions: Educational intervention for diet and physical activity, Educational message on skin cancer awareness; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 760 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Corpus Christi, Texas

Conditions: Stroke
Interventions: Standard, Incentive, Salience, Incentive + Salience; Behavioral
Lead sponsor: Indiana Institute for Medical Research; Other
Eligibility: 18 Years and older
Enrollment: 641 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Cardiovascular Disease
Interventions: Rimonabant, Placebo (for Rimonabant); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 55 Years and older
Enrollment: 18,695 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Atrial Fibrillation, Atrial Flutter, Stroke, Embolism, Systemic Arterial, Major Bleeding
Interventions: Home Monitoring Guided OAC, Physician-Directed OAC; Drug
Lead sponsor: Biotronik, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 2,718 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 73
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Anaheim, California + 70 more

Conditions: Cardiovascular Disease
Interventions: bococizumab (PF-04950615), Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 16,784 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 545
States / cities: Athens, Alabama • Birmingham, Alabama • Fort Payne, Alabama + 339 more

Conditions: Acute Brain Injury, Traumatic Brain Injury, Intracranial Hemorrhage, Hydrocephalus, Stroke, Brain Neoplasm, Hypoxia-Ischemia, Brain
Interventions: Not listed
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 2 Years to 17 Years
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Stroke, Intracranial Stenosis
Interventions: Not listed
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Acute Ischemic Stroke Related to Tandem Occlusion, Acute Ischemic Stroke Due to Isolated Cervical Artery Occlusion
Interventions: Not listed
Lead sponsor: Azienda Unità Sanitaria Locale della Romagna; Other
Eligibility: Not listed
Enrollment: 4,230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension, Hypertension (HTN), Stroke Prevention, Cardiovascular Risk Factor
Interventions: Technology-enabled Telehealth Care Plan, Blood Pressure Monitoring Device, Tenovi Smart Pillbox, Wearable Activity Trackers (Fitbit or Apple Watch), Healthie EHR, Secure Messaging Platforms (TigerConnect, Weave, AirCall), Antihypertensive Medication Management, Statin Medication Management, Antiplatelet or Anticoagulant Therapy, Laboratory Blood Test Collection; Behavioral · Device · Other + 2 more
Lead sponsor: Syntrillo, Inc; Other
Eligibility: 30 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Stroke
Interventions: Haloperidol, Typical Antipsychotics, Atypical Antipsychotics; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 1,234,412 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Titusville, New Jersey

Conditions: Cardiovascular Disease, Stroke
Interventions: Personalized Heart Attack and Stroke Risk, Standard Education; Other
Lead sponsor: Durham VA Medical Center; Federal
Eligibility: 55 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Coronary Heart Disease, Stroke, Diabetes, Breast Cancer, Ovarian Cancer, Colorectal Cancer
Interventions: Familial risk assessment and personalized prevention messages; Behavioral
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 35 Years to 65 Years
Enrollment: 8,400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 3
States / cities: Evanston, Illinois • Leawood, Kansas • Ann Arbor, Michigan

Search by objective public record fields.

Stroke Incidence and Risk Factors in a Tri-ethnic Region

Computerized Decision Support to Prevent Stroke in Atrial Fibrillation

DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation

Genetic and Environmental Risk Factors for Hemorrhagic Stroke

Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

Heart Disease on the Mend

The AHA Oneida Study

Personalized Cardiovascular Risk Information to Initiate and Maintain Health Behavior Changes

Examining the Long-Term Risks of Oophorectomy

Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter

Stroke Prevention in the Wisconsin Native American Population

Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke

Stroke Health and Risk Education (SHARE)

MINDSPACE Strategy for Risk Optimization

Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes

Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk

The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Bedside Cranial Ultrasound for Risk-Stratified Imaging in Pediatric Acute Brain Injury

Characterizing Hemodynamic Compensation in Patients With Intracranial Stenosis

Risk Factors and Outcomes of Ischemic Stroke Associated With Tandem or Isolated Cervical Artery Occlusion in Anterior and Posterior Circulation

Syntrillo Telehealth Stroke Risk Reduction Study

A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age Group

The Effectiveness of Personalized Stroke Risk Communication

Evaluating Tools for Health Promotion and Disease Prevention